261 related articles for article (PubMed ID: 7792800)
21. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
Edwards CR; Stewart PM
J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
[TBL] [Abstract][Full Text] [Related]
22. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the human gene encoding the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
Agarwal AK; Rogerson FM; Mune T; White PC
J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):473-9. PubMed ID: 8547172
[TBL] [Abstract][Full Text] [Related]
25. Human 11 beta-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue.
Bujalska I; Shimojo M; Howie A; Stewart PM
Steroids; 1997 Jan; 62(1):77-82. PubMed ID: 9029719
[TBL] [Abstract][Full Text] [Related]
26. Identification of a kinetically distinct activity of 11beta-hydroxysteroid dehydrogenase in rat Leydig cells.
Ge RS; Gao HB; Nacharaju VL; Gunsalus GL; Hardy MP
Endocrinology; 1997 Jun; 138(6):2435-42. PubMed ID: 9165033
[TBL] [Abstract][Full Text] [Related]
27. Characterization of 11beta-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK1: evidence for a third isoform?
Möbus E; Hermans JJ; Maser E
Endocrine; 1999 Dec; 11(3):301-7. PubMed ID: 10786827
[TBL] [Abstract][Full Text] [Related]
28. Transcription activation of mouse mammary tumor virus-chloramphenicol acetyltransferase: a model to study the metabolism of cortisol.
Warriar N; Pagé N; Govindan MV
Biochemistry; 1994 Nov; 33(43):12837-43. PubMed ID: 7947689
[TBL] [Abstract][Full Text] [Related]
29. Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life.
Stewart PM; Whorwood CB; Mason JI
J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):465-71. PubMed ID: 8547171
[TBL] [Abstract][Full Text] [Related]
30. Structure and function of the hepatic form of 11 beta-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance.
Moore CC; Mellon SH; Murai J; Siiteri PK; Miller WL
Endocrinology; 1993 Jul; 133(1):368-75. PubMed ID: 8319583
[TBL] [Abstract][Full Text] [Related]
31. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system.
Seckl JR; Chapman KE
Eur J Biochem; 1997 Oct; 249(2):361-4. PubMed ID: 9370341
[TBL] [Abstract][Full Text] [Related]
32. Porcine placental 11 beta-hydroxysteroid dehydrogenase activity.
Klemcke HG; Christenson RK
Biol Reprod; 1996 Jul; 55(1):217-23. PubMed ID: 8793078
[TBL] [Abstract][Full Text] [Related]
33. Apparent mineralocorticoid excess syndromes.
Shimojo M; Stewart PM
J Endocrinol Invest; 1995; 18(7):518-32. PubMed ID: 9221270
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of nuclear 11beta-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues.
Petrelli MD; Lim-Tio SS; Condon J; Hewison M; Stewart PM
Endocrinology; 1997 Jul; 138(7):3077-80. PubMed ID: 9202257
[TBL] [Abstract][Full Text] [Related]
35. [11 beta-Hydroxysteroid dehydrogenase].
Sun G; Li P; Yang KP; Challis JR
Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):301-6. PubMed ID: 12501657
[TBL] [Abstract][Full Text] [Related]
36. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Tomlinson JW; Stewart PM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
[TBL] [Abstract][Full Text] [Related]
37. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
38. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
39. The metabolism of 9 alpha-fluorinated steroids in the human kidney.
Diederich S; Hanke B; Bähr V; Oelkers W
Endocr Res; 1996 Nov; 22(4):803-10. PubMed ID: 8969943
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 11 beta-hydroxysteroid dehydrogenase in spontaneously hypertensive and Wistar-Kyoto rats.
Hermans JJ; Steckel B; Thijssen HH; Janssen BJ; Netter KJ; Maser E
Steroids; 1995 Nov; 60(11):773-9. PubMed ID: 8585102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
